Zhongxin Fluoro Materials: Net profit attributable to parent company in the first quarter was 2.5536 million yuan, a year-on-year decrease of 90.68%

stock analyst • • stock options

Zhongxin Fluoro Materials released its first quarter report for 2024. The net profit attributable to the parent company in the first quarter was 2.5536 million yuan, a year-on-year decrease of 90.68%.

Zhongxin Fluoro Materials released its first quarter report for 2024. The net profit attributable to the parent company in the first quarter was 2.5536 million yuan, a year-on-year decrease of 90.68%.

Like (0)
stock analyststock analyst
Previous April 25, 2024 8:00 pm
Next April 25, 2024 8:00 pm

Related posts

  • Yiming Pharmaceutical (002826.SZ): Net profit in the first quarter was 27.8991 million yuan, a year-on-year increase of 233.58%

    Gelonghui April 25 | Yiming Pharmaceutical (002826.SZ) announced the first quarter report of 2024. The operating income during the reporting period was 160 million yuan, a year-on-year decrease of 6.42%; the net profit attributable to shareholders of the listed company was 27.8991 million yuan, a year-on-year increase. 233.58%; net profit excluding non-recurring gains and losses attributable to shareholders of listed companies was 1.77998 million yuan, a year-on-year decrease of 77.30%; basic earnings per share was 0.15 yuan.

    stock options April 25, 2024

  • Stocks that will see action today: July 11, 2024

    State Bank of India has raised ₹10,000 crore at a coupon rate of 7.36 per cent through its sixth infrastructure bond issuance. The issue attracted an enthusiastic response from investors with bids in excess of ₹18,145 crore and was oversubscribed by around 3.6 times against the base issue size of ₹5,000 crore.

    stock options July 13, 2024

  • Volkswagen abandons all-electric plan

    Volkswagen has reportedly abandoned plans to go all-in on electric cars

    stock options May 16, 2024

  • Dongguan Securities\’ characteristic financial and business education platform \”Financial and Business Enlightenment, Accompanying You as a Child\” was selected as the \”Best Investor Education Outstanding Innovation Case\”

    Special Topic: Sina Finance’s 2024 Annual Investment Education Case Selection is in Progress. For stock trading, look at Jin Qilin’s analyst research reports, which are authoritative, professional, timely and comprehensive to help you tap potential theme opportunities! Sina Finance’s “2024 Excellent Investment Education Case Selection” event was officially launched on April 8. The unique financial and business education platform \”Financial and Business Enlightenment, Accompanying You as a Child\” created by Dongguan Securities Investment Education Base was selected as the \”Best Outstanding Innovation Case in Investor Education\”. >> Details of the event It is reported that in response to the call of the Securities Association of China to carry out the \”Investor Education in Hundreds of Schools\” event, to guide primary and secondary school students to establish correct financial concepts and enhance primary and secondary school students\’ financial security awareness and financial literacy, Dongguan Securities Investment Education Base Create a unique financial and business education platform, and bring financial and business education to primary and secondary school students through the promotion of online financial and business education investment education works and…

    stock options April 25, 2024

  • South Korea\’s central bank says the chip industry\’s upward cycle may last until at least the first half of next year

    A report released by the Bank of Korea on Friday said that the upward cycle of the chip manufacturing industry may last until the first half of next year or even longer, thus boosting South Korea\’s exports.

    stock options May 24, 2024

  • Xinhua Pharmaceutical: Net profit in the first quarter of 2024 was 142 million yuan, a year-on-year decrease of 6.41%

    CSI Intelligent Financial News Xinhua Pharmaceutical (000756) disclosed its first quarter report for 2024 on April 26. In the first quarter of 2024, the company achieved total operating income of 2.475 billion yuan, a year-on-year decrease of 6.25%; net profit attributable to the parent company was 142 million yuan, a year-on-year decrease of 6.41%; non-net profit after deduction was 138 million yuan, a year-on-year decrease of 6.41%; Net cash flow was 38.0634 million yuan, compared with -184 million yuan in the same period last year; during the reporting period, Xinhua Pharmaceutical\’s basic earnings per share was 0.21 yuan, and the weighted average return on net assets was 3.04%.

    stock options April 25, 2024